Otrivin (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin, is a nasal decongestant presented as a 0.1% solution for topical nasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children over 6 years of age.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin (xylometazoline) acts on the nasal mucosa to reduce swelling and improve airflow. - Common cold: Reduces nasal blockage and promotes ease of breathing. - Acute sinusitis: Helps decongest inflamed nasal passages and facilitates drainage. - Allergic rhinitis: Alleviates congestion caused by seasonal allergens and pollutants. - Nasal surgery post‑operative care: Minimises swelling and supports post‑operative breathing comfort.

Side effects are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning sensation: A transient, mild burning feeling in the nostrils. - Stinging : t  t  t t t t t.\n- Nasal dryness: Reduced moisture leading to a feeling of dryness.\n- Sneezing: Reflex irritation causing occasional sneeze . - Headache : M t  g - Irr Irr  g

Serious or Rare Side Effects: - Rebound congestion: Worsening nasal blockage after prolonged use (>3‑5 days). - Severe nasal irritation : including ulcers or bleeding of the mucosal lining . - Allergic reaction : rash and h  ewline -